# Shao Q. Yao

**Shao Q. Yao** (Shao Qin Yao) is a chemical biologist and medicinal chemist who has been on the faculty of the [National University of Singapore](https://www.edgepedia.org/national-university-of-singapore) (NUS) since March 2001.<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup><sup> • </sup><sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> His research develops chemical-proteomic tools for organism-wide, high-throughput study of enzymes, an approach his group calls "catalomics," along with activity-based probes and methods for delivering proteins into living cells.<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup>

| Key facts | |
| --- | --- |
| Full name | Shao Qin Yao<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup> |
| Position | Professor (Chemistry), National University of Singapore, 2 March 2001 to present<sup>[3](https://orcid.org/0000-0003-4715-769X)</sup> |
| Training | B.Sc. Ohio State University (1993); PhD Purdue University (1998, Jean A. Chmielewski); postdoc with Peter G. Schultz at UC Berkeley and Scripps Research Institute<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> |
| Known for | Activity-based probes, "catalomics" chemical proteomics, intracellular protein delivery<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup> |
| Signature work | Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian Cells, *Journal of the American Chemical Society*, 2024<sup>[4](https://doi.org/10.1021/jacs.4c07181)</sup> |
| Dean's Chair Professor | NUS, 2009 to 2012<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> |

## Education and career

Yao was born in China and received his B.Sc. with honors from [Ohio State University](https://www.edgepedia.org/ohio-state-university) in 1993.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> His PhD at [Purdue University](https://www.edgepedia.org/purdue-university), completed in 1998, was in bioorganic chemistry and de novo peptide and protein design, under Prof. Jean A. Chmielewski.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> After a fellowship from the Cancer Research Institute (USA) in 1998, he carried out postdoctoral research first at the [University of California](https://www.edgepedia.org/university-of-california), Berkeley, and then at the Scripps Research Institute, both under Prof. Peter G. Schultz.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup>

He joined NUS in March 2001 as an assistant professor with a joint appointment in the Department of Chemistry and the Department of Biological Sciences, was promoted to Associate Professor on 1 January 2006, and became Full Professor in 2011.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> ORCID records his appointment as Professor (Chemistry) from 2 March 2001 to the present.<sup>[3](https://orcid.org/0000-0003-4715-769X)</sup> He held the Dean's Chair Professorship at NUS from 2009 to 2012.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup>

## Research: activity-based probes and catalomics

The Yao Lab builds enabling platforms for high-throughput study of enzymes, including kinases, phosphatases, and proteases.<sup>[5](https://blog.nus.edu.sg/yaolab/research/)</sup> Its tools include activity-based probes (ABPs) and chemical compound libraries assembled by combinatorial synthesis or "click chemistry" and screened in high-throughput using microplates or microarrays.<sup>[5](https://blog.nus.edu.sg/yaolab/research/)</sup>

**Catalomics** is the name his group gives to this program: a field of chemical biology in which chemical and biological tools enable large-scale studies of enzymes and their reader proteins at the organism level.<sup>[6](https://iam.njtech.edu.cn/en/info/1035/1383.htm)</sup> The motivation is pharmacological: nearly one-third of all current drug targets are enzymes.<sup>[6](https://iam.njtech.edu.cn/en/info/1035/1383.htm)</sup> His stated research areas also include microarray-based discovery against normally undruggable targets such as phospho- and K(ac) reader proteins, "in situ drug profiling" for cell-based proteome-wide identification of on- and off-targets of FDA-approved drugs and natural products, and material chemical biology methods for intracellular delivery of small molecules, genetic materials, and proteins.<sup>[6](https://iam.njtech.edu.cn/en/info/1035/1383.htm)</sup>

A recent strand applies ABPs to the catalytic lysine of protein kinases. His group developed lysine-reactive probes based on aryl fluorosulfates (ArOSO2F) capable of global reactivity profiling of the catalytic lysine across the human kinome from mammalian cells; chemoproteomic studies with these probes profiled more than 300 endogenous kinases, giving a global landscape of ligandable catalytic lysines.<sup>[7](https://doi.org/10.1002/anie.202316394)</sup> [X-ray crystallography](https://www.edgepedia.org/x-ray-crystallography) and mass spectrometry confirmed covalent engagement between the aryl fluorosulfate and the catalytic lysine of SRC kinase, and installing this aminophile into the kinase inhibitor VX-680 produced lysine-reactive targeted covalent inhibitors with in vitro potency, cellular activity, and prolonged residence time.<sup>[7](https://doi.org/10.1002/anie.202316394)</sup>

## Representative work

According to the paper [Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian Cells published in *Journal of the American Chemical Society* on 20 August 2024, it reported the first small-molecule-induced chemical strategy capable of global acetylation of the catalytic lysine on kinases from mammalian cells.<sup>[4](https://doi.org/10.1021/jacs.4c07181)</sup> One compound, Ac4, acetylated the catalytic lysine of more than 100 different protein kinases from live Jurkat and K562 cells.<sup>[4](https://doi.org/10.1021/jacs.4c07181)</sup> Building on the noncovalent AURKA inhibitor VX-680, the group developed six acetylating compounds; Ac13 and Ac14 showed robust, target-selective acetylation of AURKA's catalytic lysine K162, leading to irreversible inhibition of endogenous kinase activity.<sup>[4](https://doi.org/10.1021/jacs.4c07181)</sup> The acetylation was shown to be reversible: recombinant AURKA treated with Ac14 was deacetylated by the lysine deacetylase SIRT3.<sup>[4](https://doi.org/10.1021/jacs.4c07181)</sup>

## Intracellular protein delivery

Yao's group addresses protein delivery under the banner of material chemical biology, developing methods for intracellular delivery of small molecules, genetic materials, and proteins.<sup>[6](https://iam.njtech.edu.cn/en/info/1035/1383.htm)</sup> The lab's publication list includes work on intracellular delivery of protein-based therapeutics for targeted oncogenic MYC degradation in mammalian cells and mice, and on rational design of nanocarriers for protein delivery (*Advanced Materials*, 2019, 31, 1902791).<sup>[8](https://blog.nus.edu.sg/yaolab/publications/)</sup> The lab also holds US Patent No. 7,449,558, "Site-Specific Labelling of Proteins," granted 11 November 2008, was, according to the Yao Lab biography, co-invented by Yao and Yeo S.Y.D.<sup>[2](https://blog.nus.edu.sg/yaolab/120-2/)</sup> 

## Recent developments

NUS reports a self-assembled nano-molecular glue, Cle-NP, built on fumarate-based molecular glue handles attached to ligands of therapeutic kinases including TBK1, FGFR, and Bcr-Abl; the nanoparticle caused tumor-specific degradation of endogenous Bcr-Abl and tumor regression in a K562-xenografted mouse model with good biosafety profiles.<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup>

## Honors and service

Yao's awards include the A*STAR Singapore Young Investigator Award (2002), the NUS Young Research Award (2005), the Mr & Mrs Sun Chan Memorial Award (2006), the NUS Faculty of Science Outstanding Scientist Award (2007), and the international ASAIHL-Scopus Young Scientist Award (2008).<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup> He joined the International Scientific Advisory Board of *Angewandte Chemie*.<sup>[1](https://chemistry.nus.edu.sg/people/yao-shao-qin/)</sup>

## References

1. YAO Shao Qin – NUS Chemistry. https://chemistry.nus.edu.sg/people/yao-shao-qin/
2. The Yao Lab – Professor Yao Shao Qin (biography). https://blog.nus.edu.sg/yaolab/120-2/
3. Shao Yao – ORCID 0000-0003-4715-769X. https://orcid.org/0000-0003-4715-769X
4. Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian Cells. *JACS* 2024. https://doi.org/10.1021/jacs.4c07181
5. The Yao Lab – Research. https://blog.nus.edu.sg/yaolab/research/
6. Research Seminar of Prof. Yao Shaoqin from National University of Singapore (NJTech, 2017). https://iam.njtech.edu.cn/en/info/1035/1383.htm
7. Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development. *Angewandte Chemie* 2024. https://doi.org/10.1002/anie.202316394
8. The Yao Lab – Publications and patents list. https://blog.nus.edu.sg/yaolab/publications/

---
*Topic: Encyclopedia › Physical world and mathematics › Physical and mathematical scientists › Chemists › Researchers in organic synthesis, organometallic, and medicinal chemistry › Chemical biology and bioorthogonal chemistry*

*Initially written Sep 21, 2026 · Reviewed: Sep 25, 2026; Sep 30, 2026 · Edited: Sep 25, 2026; Oct 15, 2026; Oct 21, 2026; Oct 25, 2026 · Last review: Sep 30, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license
